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Cranial neural crest (CNC) is a multipotent migratory cell population that gives rise to most of the craniofacial bones. An intricate
network mediates CNC formation, epithelial-mesenchymal transition, migration along distinct paths, and differentiation. Errors in
these processes lead to craniofacial abnormalities, including cleft lip and palate. Clefts are the most common congenital craniofacial
defects. Patients have complications with feeding, speech, hearing, and dental and psychological development. Affected by both genetic
predisposition and environmental factors, the complex etiology of clefts remains largely unknown. Here we show that Fas-associated
factor-1 (FAF1) is disrupted and that its expression is decreased in a Pierre Robin family with an inherited translocation. Furthermore,
the locus is strongly associated with cleft palate and shows an increased relative risk. Expression studies show that faf1 is highly ex-
pressed in zebrafish cartilages during embryogenesis. Knockdown of zebrafish faf1 leads to pharyngeal cartilage defects and jaw abnor-
mality as a result of a failure of CNC to differentiate into and express cartilage-specific markers, such as sox9a and col2a1. Administration
of faf1mRNA rescues this phenotype. Our findings therefore identify FAF1 as a regulator of CNC differentiation and show that it predis-
poses humans to cleft palate and is necessary for lower jaw development in zebrafish.Introduction
The formation of the jaw, a pharyngeal arch derivative,
depends on the migration of cranial neural crest cells
from one part of the embryo to another.1 Defects in this
process cause cleft clip and/or palate (OFC1 [MIM
119530]), a common craniofacial birth defect (1/700 live
births).2 Clefts are notable for their lifelong morbidity.
Patients often present complex problems, and they have
to undergo several surgical and nonsurgical treatments
that can considerably reduce the quality of life and have
a major impact on the patients and their families. Accord-
ing to epidemiological and genetic studies, clefts are
divided into cleft lip with or without palate (CL/P) and
cleft palate only (CPO).2 They are mainly nonsyndromic
(70% of CL/P and 50% of CPO) and have a complex,
largely unknown etiology.3 Genetic factors involved in iso-
lated clefts have been identified on the basis of association
studies, animal models, and role in known human cleft
syndromes. The Interferon regulatory factor-6 gene (IRF6
[MIM 607199]) has been shown to be associated with iso-
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less, no gene has been shown to be associated with isolated
CPO. The Pierre Robin Sequence (PRS [MIM 261800]) is
a subgroup of cleft palate. It is characterized by CPO,
micrognathia, and glossoptosis8 and was first described
by Robin (1923) as a condition in which the tongue tends
to obstruct the airway and lead to feeding and respiratory
difficulties during the early postnatal period. Some insights
into its etiology have been obtained by studies showing
association with conserved noncoding elements flanking
the SRY-box 9 gene (SOX9 [MIM 608160]).9
In this study, we characterize the role of FAF1 [MIM
604460] in orofacial development. We show that FAF1
haploinsufficiency causes CPO in one PRS family. Sporadic
CPO patients have significantly decreased FAF1 expres-
sion. Furthermore, association studies conducted on
7597 individuals show that the locus is strongly associated
with CPO; on average, relative risk is increased 1.47-fold in
individuals with the associated allele. Because the role of
FAF1 during development was not known, we character-
ized its function in zebrafish embryos. Results show that
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and for CNC differentiation into cartilage. We conclude
that FAF1 plays a role in the etiopathogenesis of cleft palate
and is a key molecule in development.Material and Methods
Families
Data from families in the Belgian cohort were collected in collab-
oration with the CL/P Center, Cliniques Universitaires Saint-Luc,
Brussels, Belgium and the CHU de Lille, Hoˆpital Jeanne de Flandre,
Lille, France. We obtained informed consent from participants
prior to conducting the study, as approved by the institutional
review board and local ethics committees. Patients were evaluated
by contributing physicians and asked about familial cleft history.
Venous blood samples were drawn for each participant. DNA
was extracted from whole blood and/or buccal cell swabs.10 For
the family with a translocation, no DNA was available from the
aunt or the grandparents. RNA was extracted from lymphocytes
with the TriPure Isolation Reagent (Roche), and cDNA synthesis
was performed with the iScript cDNA Synthesis Kit (Bio-Rad)
according to the manufacturer’s instructions.
Cytogenetics
BAC and fosmid clones were identified via the Ensembl and UCSC
genome browser databases and obtained from the BACPAC
Resource Center (CHORI). Karyotyping and metaphase spreading
for fluorescence in situ hybridization (FISH) analysis were made
from a fixed cell suspension of 3-day-cultured, phytohemagglu-
tinin-stimulated peripheral blood lymphocytes. DNA probes
were differentially labeled with the BioPrime DNA labeling System
(Invitrogen). Probes were denatured, pre-annealed with human
Cot-1 DNA (Invitrogen), and hybridized onto the denatured slides
overnight at 37C in a moist chamber. Signals were detected with
FITC-avidin and rhodamine- antidigoxigenin monoclonal anti-
body. Slides were air-dried and mounted with Vectashield and
DAPI. At least five metaphases were analyzed for each hybridiza-
tion with a Zeiss Axioplan 2 epifluorescence microscope (Carl
Zeiss). Metaphases were captured with Isis software (Metasystems
GmbH).
Microdissection, Reverse Array,
and Chromosome Painting
Chromosome microdissection, reverse array, and chromosome
painting were done as previously described.11 In brief, fresh cells
were dropped on a coverslip before trypsin-Giemsa banding was
performed. Under an inverted microscope, rearranged chromo-
somes (1 and 2) were identified and dissected with a glass needle.
Four copies were separately transferred into a collection tube and
incubated with Proteinase K at 37C for 2 hr. DNA was amplified
by DOP-PCR, tested for amplification efficiency, and labeled by
a second-roundDOP-PCRwith the SpectrumOrange-dUTP fluores-
cent dye. Chromosomal microdissection was tested by reverse
hybridization to normal human metaphases as a control, and by
array-based comparative genomic hybridization using arrays
described elsewhere.11
Multiplex Polymerase Chain Reaction/Liquid
Chromatography Assay
A 316 bp and a 377 bp cDNA fragment from FAF1 (MIM 604460)
and a Ras p21 protein activator 1 (RASA1 [MIM 139150]) controlThe Americagene, respectively, were amplified via multiplex polymerase chain
reaction (PCR). Aliquots of 5 ml of PCR products were injected on
a semi-automated 3500 Wave HS system (Transgenomic). DNA
was eluted, mixed with the Wave HS Staining Solution I, and
detected via fluorescence. Data were analyzed with Navigator
1.6.4 software.
Association Studies
Association studies were conducted on a cohort of 7597 available
individuals of different geographic origins (2530 trios, each
including a patient with nonsyndromic cleft and that patient’s
two parents) (Table 1). Cleft patients from Belgium, the Eurocran
and Italcleft study (see Web Resources), Germany, Texas, Iowa,
and the Philippines were genotyped for a total of ten SNPs
capturing as much information as possible: tagging SNPs (r2 R
0.8), a high coverage of FAF1, and/or a minor allele frequency
cutoff of 0.2 (Figure S1). We analyzed the different cohorts
separately to replicate FAF1 association results. We then merged
populations to increase the statistical power of the calculations.
We performed a transmission disequilibrium test (TDT) by subdi-
viding the data on the basis of proband cleft type. Genotypes
were considered from complete parent-child trios (all incomplete
trios or trios with incomplete genotypes were excluded). Associa-
tion between markers and clefts was tested with FBAT and APL
(See Table 1 for SNPs genotyped).12,13 Relative risks (RR) associated
with the genotype of the child were calculated via a log-linear
approach under the assumption of a recessive model (risk of TT
genotypes compared to TC þ CC).14
Mutation Analysis
A pilot cohort of available patients was screened for mutations in
FAF1 (NM_007051.2). In total, 228 individuals with different cleft
types were analyzed. Because mutations in IRF6 account for
63% of patients with van der Woude syndrome (VWS [MIM
119300]),15 we includedVWSpatients for whom IRF6was screened
and excluded (n ¼ 14).16 The cohort also included patients with
CPO(n¼65), PRS (n¼34), andCL/P (n¼115). Exons1–21andcor-
responding exon-intron boundaries of FAF1 were PCR-amplified
from genomic DNA and subjected to mutation analysis via dena-
turing high-performance liquid chromatography (DHPLC) on
a semi-automated 3500 Wave HS system (Transgenomic). Each
sample with an abnormal profile was purified (QIAGEN) and
sequenced on a CEQ2000 fluorescent capillary sequencer (Beck-
manCoulter).We usedDHPLC to assess cosegregation of identified
changes with the phenotype.
Real-Time Quantitative PCR
Two controls and nine patients (5 CLP, 4 CPO) from whom RNA
from lymphocytes was available were chosen for FAF1 expression
studies. Real-time qPCR was performed in an iCycler thermocycler
and MyiQ detection System (Bio-Rad) with the SYBR Green PCR
Master Mix (Applied Biosystems). Quantification of FAF1 was
based on standard curves constructed from 5-fold serially diluted
normal genomic DNA. The relative copy number of FAF1 was
calculated against ACTB.
Zebrafish Whole-Mount In Situ Hybridization
and Alcian Blue Staining
Dechorionated embryos were fixed overnight in 4% paraformalde-
hyde at 4C. Whole-mount in situ hybridization was performed
as described17 with antisense probes for faf1, cmlc2,18 islet1,19n Journal of Human Genetics 88, 150–161, February 11, 2011 151
Table 1. Association Results
Population Origin
(in Collaboration with)
Genotyped SNPs
(Major/Minor allele) Cleft Type
Number of
Individuals
(T ¼ 7597)
Number of
Affected
Individuals
Associated SNP
(Associated Allele)
Familial
History
DT p Value
s1149795
TDT p Value
rs3827730
Relative risk of CPO
Conferred by TT Genotype
of rs3827730; p value
Belgium rs6588392 (C/G), rs11205768 (T/C),
rs17387761(G/A), rs3827730 (T/C)
mixed 1072 421 rs3827730 (T) S /A 0.004
CPO 325 126 rs3827730 (T) S /A 0.001 2.72 (1.49-4.98);
p ¼ 0.001
CL 227 94 none S /A 0.23
CLP 520 202 none S /A 0.45
CL/P 747 296 none S /A 0.15
European descent- Iowa,
USA (J. Murray)
rs11205760 (C/T), rs1149795 (T/C),
rs3827730 (C/T), rs2784143 (C/T),
rs2455636 (G/A)
mixed 981 350 rs1149795 (C) F þ S .006 0.16
CPO 246 90 rs1149795 (C) F þ S .02 0.34 1.23 (0.6–2.53);
p ¼ 0.569
CL 275 91 none F þ S .67 0.78
CLP 412 146 none F þ S .61 0.34
CL/P 42 22 none F þ S .1 0.65
European descent- Texas,
USA (J. Hecht)
rs3827730 (T/C) CL/P 499 N/A rs3827730 (T) F þ S /A 0.38
Mexican Hispanics- Texas,
USA (J. Hecht)
rs3827730 (T/C) CL/P 177 N/A rs3827730 (T) F þ S /A 0.14
Philippines (J. Murray) rs11205760 (C/T), rs1149795 (T/C),
rs3827730 (T/C), rs2784143 (C/T),
rs2455636 (G/A)
mixed 2511 570 none F .73 0.62
CPO 22 4 none F I 0.52
CL 429 98 none F 0.93
CLP 1203 246 none F .86 0.78
CL/P 823 212 none F .51 0.29
Germany (E. Mangold) rs11205760 (C/T), rs17387761 (G/A),
rs11587909 (C/T), rs17382596 (T/G),
rs3827730 (T/C)
mixed 1514 679 none N/A /A 0.16
CPO 242 99 none N/A /A 0.78 1.17 (0.63-2.17); p ¼ 0.624
CL 225 99 none N/A /A 1
CLP 1047 481 none N/A /A 0.12
CL/P 1272 580 none N/A /A 0.16
1
5
2
T
h
e
A
m
e
rica
n
Jo
u
rn
a
l
o
f
H
u
m
a
n
G
e
n
e
tics
8
8
,
1
5
0
–
1
6
1
,
Fe
b
ru
a
ry
1
1
,
2
0
1
1T
r
N
N
N
N
N
0
0
0
0
0
N
N
0
N
1
0
0
N
N
N
N
N
Table 1. Continued
Population Origin
(in Collaboration with)
Genotyped SNPs
(Major/Minor allele) Cleft Type
Number of
Individuals
(T ¼ 7597)
Number of
Affected
Individuals
Associated SNP
(Associated Allele)
Familial
History
TDT p Value
rs1149795
TDT p Value
rs3827730
Relative risk of CPO
Conferred by TT Genotype
of rs3827730; p value
Eurocran and Italcleft: IT, NL,
UK, HU, SL, ET, SK, and BU
(M. Rubini)
rs1149795 (T/C), rs3827730 (C/T),
rs17382596 (T/G)
CPO 843 281 rs3827730 (T) S 0.67 0.007 1.38 (1.02-1.87); p ¼ 0.036
NL CPO 165 55 none S N/A 0.42 1.02 (0.51-2.05); p ¼ 0.955
IT CPO 183 61 rs3827730 (T) S N/A 0.02 2.04 (1.06-3.96); p ¼ 0.034
UK CPO 201 67 none S N/A 0.43 1.44 (0.77-2.70); p ¼ 0.252
Eurocran Western Europe
(NL þ IT þ UK)
CPO 549 183 rs3827730 (T) S N/A 0.03 1.43 (0.98- 2.08); p ¼ 0.064
Eurocran Eastern Europe
(HU, SL, ET, SK, BU)
CPO 294 98 none S N/A 0.09 1.38 (0.82-2.30); p ¼ 0.224
Belgium þ Germany þ
Eurocran and Italcleft
rs3827730 (C/T) CPO 1410 506 rs3827730 (T) SþN/A N/A 0.0007 1.51 (1.18-1.93); p ¼ 0.001
Belgium þ Germany þ
Eurocran and Italcleft þ Iowa
rs3827730 (C/T) CPO 1656 596 rs3827730 (T) FþS N/A 0.0003 1.47 (1.17-1.86); p ¼ 0.001
TDT was done with the FBAT program for all populations except the European-descent cohort from Texas (APL). Notations are as follows: mixed, all cleft types together (CPO þ CL þ CLP); CPO, cleft palate only; CL, cleft lip;
CLP, cleft lip and palate; CL/P, ceft lip with or without cleft palate; F, familial; S, sporadic; N/A, not available; NI, not informative; T, total; IT, Italy; NL, The Nerherlands; UK, The United Kingdom; HU Hungary; SL Slovenia; ET,
Estonia; SK, Slovakia; and BU, Bulgaria. Note that in the CPO cohort from Belgium, 38 patients had isolated PRS (CPO þ retrognatia), all others had CPO.
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myoD,20 snail1b,21 crestin,22 sox10,23 foxd3,24 dlx2,25 sox9a,26
and col2a1.27 Cartilages were visualizedwith Alcian blue according
to a modified protocol.28 In brief, 5 dpf larvae were fixed
and washed several times in phosphate-buffered saline with
0.1% Tween-20 (PBST). Subsequently, embryos were transferred
into a filtered Alcian blue solution (1% concentrated hydrochloric
acid, 70% ethanol, and 0.1% Alcian blue) and stained overnight
at room temperature. Specimens were cleared in acidic ethanol
(5% concentrated hydrochloric acid and 70% ethanol) for 4 hr,
rehydrated in an ethanol series, and stored in 70% glycerol/
PBS. Stained embryos were imaged with a Zeiss Lumar V12
stereomicroscope.
Zebrafish faf1 Knockdown Analysis
Tg(fli1:EGFP)y1 zebrafish29 were maintained under standard labo-
ratory conditions. The following morpholino oligonucleotides
were purchased from Gene Tools: 50- TGTCCATGTTGCTGTCGGA
GGCCAT-30 (faf1-MO-ATG), 50- ATGTGAGAAAACCCACCTGAAA
GTC-30 (faf1-MO-Splice), both used for knockdown of faf1 expres-
sion, and 50- TGTgCATcTTGCTcTCGGAcGCgAT-30, mismatched
at five base pairs, as a control. Different doses of morpholinos
were injected into single- to four-cell stage zebrafish embryos via
procedures previously described.17 All data shown were obtained
after injection of 2–6 ng faf1-MO-ATG or 8–16 ng faf1-MO-Splice
per embryo. At least 30–40 injected embryos were analyzed per
experiment,and each experiment was repeated at least three times.
We scored the penetrance of the phenotype by counting the
affected embryos. To block apoptosis, we coinjected a p53 target-
ing morpholino (50- GACCTCCTCTCCACTAAACTACGAT-30) at
13 to 1.53 the concentration of the ATG or splice-blocking
morpholino.30 To test efficacy of faf1-MO-ATG, we cloned the
25 nucleotides of the 50 UTR, the ATG, and 40 nucleotides of
the coding sequence of faf1 (containing the ATG) in an expression
vector, upstream of and in frame with the luciferase cDNA (lacking
the initiator ATG codon). Expression of this chimeric reporter
protein in the erythrocyte lysate assay was monitored via
luminometry. We tested the efficacy of faf1-MO-Splice by RT-
PCR on extracts of morphant embryos by using primers allowing
size-discrimination between correctly and erroneously spliced
mRNA.
Phenotypic Rescue with Zebrafish faf1 mRNA
For rescue experiments, zebrafish faf1 full-length coding sequence
was subcloned into the pCS2þ vector for in vitro transcription.
The mRNA was synthesized with Sp6 RNA polymerase and
the message machine kit (Ambion). Two hundred pg of mRNA
was injected into 1-cell-stage embryos together with faf1-MO-
Splice.Results
We identified a translocation present in a multigenera-
tional family affected by CPO and PRS. We characterized
the breakpoints and demonstrated that they occur within
a gene.We investigated the role of this gene in cleft cohorts
by conducting expression and association studies, as well
as relative risk analysis. We performed a series of morpho-
lino knockdown and rescuing assays, whole-embryo stain-
ing, and in situ hybridization to unravel the role of this
gene during zebrafish embryological development.154 The American Journal of Human Genetics 88, 150–161, FebruaryFAF1 Haploinsufficiency in Syndromic CPO
The proband is a 4-year-old boy who is of European
descent and has Pierre Robin sequence. The boy presented
a cleft of the secondary palate and associated micro/retro-
gnathia, microstomia, malar hypoplasia, and oligodontia
(Figures 1A, 1B, and 1C). His father and aunt were similarly
affected (Figure 1A). The karyotypes of the father and the
child were 46,XY,t(1;2)(p34;q33), and Affymetrix 50K
SNP Chip analysis revealed no copy-number variation
(data not shown). FISH analysis, chromosomemicrodissec-
tion followed by reverse array, chromosome painting, and
PCR on derivative chromosome 1 revealed that the 1p
breakpoint interrupted FAF1 within its first intron (Figures
1D, 1E, and 1G). A mulitplex PCR/liquid chromatography
(MP/LC) assay demonstrated lowered FAF1 expression in
lymphocytes of the child compared to controls (Figure 1F
and data not shown). Analysis of the 2q breakpoint
showed that the region is not well conserved between
humans and mice, and it has no sites for microRNAs or
regulatory elements. It contains no genes, UTRs, LINEs,
SINEs, or other repetitive interspersed or tandem-repeat
elements. Thus, it is unlikely to play a role in the observed
inherited phenotype.
FAF1 Association with Clefts
In the overall dataset of isolated CPO trios, the T allele of
rs3827730 was significantly overtransmitted from hetero-
zygous parents to affected children (p ¼ 0.0003), although
there were wide differences between countries (Table 1).
Over-transmission of the Tallele was significant in Belgium
(p ¼ 0.001). Positive association was replicated in the
Italian cohort (p ¼ 0.02) and the Western European cohort
(p ¼ 0.03). A trend of overtransmission was observed in
all countries except for Germany. The TT genotype of
rs3827730 in the child was associated with an overall
1.47-fold increased risk of CPO (when all 474 trios were
considered) (Table 1). The association was significant in
Belgium and Italy (2.72- and 2.04-fold increased risks,
respectively), but it was absent in Germany and the
Netherlands. Eastern Europe and the United Kingdom
had an approximately 1.4-fold increased risk. The Iowan
CPO subgroup showed association with the C allele of
rs1149795 (p ¼ 0.02). When all European trios were
considered, parental imprinting was not significant (data
not shown).
Decreased FAF1 Expression in Patients with Clefts
but without a Mendelian Mutation
Screening forFAF1mutations inthecohortof228 individuals
with cleft revealed four changes, including two in the coding
region (Figure 1H and Table S1). A p.Pro177Ser (c.529C>T)
substitutionwas found in one PRS family, and a p.Arg275Trp
(c.823C>T) substitutionwas found in two unrelated individ-
uals with CL/P and CL. Screening age-matched controls
revealed 3/600 individuals with p.Pro177Ser (c.529C>T)
and 3/400 with p.Arg275Trp (c.823C>T). A synonymous
change, p.Val220Val (c.660A>G), was present in 28.3% of11, 2011
Figure 1. Identification of t(1;2) Breakpoint of
the 46,XY,t(1;2)(p34;q33) Translocation
(A) Pedigree of family. An arrow indicates the pro-
band; filled symbols indicate affected individuals.
(B and C) Father (during adolescence, after
surgery), with micro/retrognathia, microstomia,
and translocation.
(D) FISHwithfosmidG248P84517F11(green) span-
ning 1p breakpoint and fosmid G248P81885B3
(red) centromeric to 1p breakpoint.
(E) Reverse chromosome painting of microdis-
sected derivative chromosome 1 red-labeled and
hybridized to normal metaphases.
(F) MP/LC multiplex chromatogram for FAF1/
RASA1. Chromatograms represent fluorescence
intensity and arenormalized to theRASA1 control
amplicon. Blue indicates a control individual; red
indicates a patient with a translocation. RASA1 is
the Ras p21 protein activator 1 gene.
(G)Mappingof amplifiedmicrodissected aberrant
chromosome 1 by array CGH. Dark squares indi-
cate log-2-transformed intensity ratios. Clones
are ordered from 1p tel to 1q tel. The first clones
with decreased and increased intensities are indi-
cated.
(H) FAF1 structure. Exons are positioned to scale.
For colored exons, the FAF1 domains are denoted
below. Probes 1–4 (pink bars in intron 1) were
amplified and sequenced from aberrant chromo-
some 1; probes 5 and 6 (black) were not amplifi-
able from either derived chromosome, and probe
7 (blue) was amplified and sequenced from aber-
rant chromosome 2. Translocation breaks FAF1
in intron 1. Arrowheads indicate the position of
identified changes and polymorphism; green
arrows indicate SNPs genotyped in the Belgian
cohort.
(I) qPCR of FAF1 on lymphocytes from controls,
CL/P, and CPO patients.400 unaffected controls and 26.3% of patients. Neither
change was statistically significantly associated with clefts.
AffymetrixSNPChipsdidnotunravel anycopy-number vari-
ation at 1p34 in 140 cleft patients (data not shown).
Because changes in regulatory regions play an important
role in complex diseases, such as clefts, FAF1 expression
was studied by quantitative RT-PCR on peripheral blood
lymphocytes from control individuals (n ¼ 2) versus cleft
patients (n ¼ 9). A significant decrease in expression wasThe American Journal of Humobserved in CPO (p ¼ 0.0015) and CL/P
(p ¼ 0.01) (Figure 1I). Genotyping the
patients for rs3827730 revealed an enrich-
ment of the T allele (75% of alleles in CPO
and 60% of alleles in CL/P patients).
Severe Jaw Defects in faf1-Knockdown
Zebrafish Embryos
In zebrafish embryos, at 24 and 30 hr post-
fertilization (hpf), faf1 transcripts were
detected by whole-mount in situ hybridiza-
tion in the pharyngeal arch primordia that
give rise to cranial cartilages (Figures 2A
and 2B). At 56 hpf, when the pharyngealcartilages are forming, faf1 was strongly expressed in all
arches; the most prominent expression was in the first
(mandibular) and second (hyoid) arch (Figures 2C and 2D).
To block faf1 expression, we injected antisense morpho-
lino oligonucleotides (designed to inhibit translation or
splicing of pre-mRNA) into 1- to 4-cell-stage zebrafish
embryos. Effective knockdown of faf1 was demonstrated
with a chimeric faf1/Luciferase fusion reporter assay: trans-
lation of the reporter in vitro was suppressed by thean Genetics 88, 150–161, February 11, 2011 155
Figure 2. faf1 Expression Studies and Pharyngeal Arch Development in Zebrafish Larvae
(A–D) Expression pattern of faf1 in control zebrafish of different stages is shown by whole-mount in situ hybridization. At 24 hpf and 30
hpf, strong faf1 expression in pharyngeal arch primordia (PP) (A and B). Dorsal views of the pharyngeal region are shown; the rostral side
is down. At 56 hpf, there is strong faf1 expression in all arches, and the most prominent expression is in the first (mandibular, M) and
second (hyoid, H) arches (C and D). Scale bars represent 100 mm.
(E–L) Ventral and side views of Alcian-blue-stained 5 dpf wild-type (E, G, I, and K) and faf1KD (F, H, J, and L) larvae; the focus is on pharyn-
geal cartilage. At 6 ng/embryo, all cartilages are generally smaller, ceratohyal cartilage is orientedmoremedially (black arrows), branchial
cartilages are partially missing (black asterisk), and Meckel’s cartilage is oriented ventrally (double black arrow), resulting in an open-
mouth-like appearance. Abbreviations for cartilege are as follows: bb, basibranchial; bh, basihyal; cb, ceratobranchial; ch, ceratohyal;
ep, ethmoid plate; hb, hypobranchial; hs, hyosymplectic; m, Meckel’s; pch, parachordal; pq, palatoquadrate; and tr, trabecula. Scale
bars represent 200 mm.
(M and N) Macroscopic side views of the head of 5 dpf control (M) and faf1KD (N) zebrafish embryos. Faf1KD embryos have an open-
mouth-like appearance (white arrow). Scale bars represent 200 mm.
(O and P) Green fluorescent protein under fli1 promoter in 2 dpf Tg(fli1:eGFP)y1 wild-type (O) and faf1KDp53KD (P) zebrafish larvae. The
CNC of pharyngeal arches defective in faf1KDp53KD zebrafish larvae is shown. Scale bars represent 50 mm.
(Q–T) sox9a (Q and R) and col2a1 (S and T) expression in wild-type (Q and S) and faf1KDp53KD (R and T) larvae. Sox9a expression is
reduced in pharyngeal arches of 30 hpf faf1KDp53KD larvae (black arrowheads); a dorsal view is shown. Col2a1 expression is absent in
the mandible of 2 dpf faf1KDp53KD larvae (black arrowhead); a dorsal view is shown. Scale bars represent 100 mm.
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translation blocking morpholino faf1-MO-ATG in a dose-
dependent manner (Figure S2A). In contrast, a control mis-
matched at five base pairs was ineffective, demonstrating
specificity of the faf1-MO-ATG morpholino (Figure S2A).
For the splice-blocking morpholino, faf1-MO-Splice, RT-
PCR analysis showed that it inhibited splicing of the faf1
pre-mRNA in morphant embryos in a dose dependent
manner (Figure S2B).
Macroscopic inspection revealed that faf1-knockdown
(faf1KD) embryos had smaller heads and an underdevel-
oped jaw region from 2 dpf onward, so that at 5 dpf they
had an ‘‘open mouth’’ phenotype (Figures 2M and 2N).
The majority of morphant embryos appeared otherwise
normal, although embryos with smaller heads and bent,
shortened bodies were observed, but only at the highest
morpholino dose. In situ hybridization of whole-mount
30 hpf embryos with probes specific for the developing
somites (myoD), (motor) neurons (islet1), and heart
(cmlc2) demonstrated normal development of these tissues
(Figure S3). The penetrance and severity of the jaw pheno-
type increased with the doses of morpholino used
(Figure S4A and Table S2). These defects were not induced
by the mismatch control.
Because the open-mouth phenotype suggested defective
cartilage development, we used whole-mount Alcian blue
staining to visualize the cartilage, especially in the facial
region. Upon injection of faf1-MO-ATG at a dose of 4 ng
per embryo, Alcian blue staining revealed a mild cartilage
defect in most embryos: there was altered orientation of
the ceratohyal cartilage, which was pointing more inward
than in controls (Figure S5B and Table S2). After a more
complete knockdown (6 ng per embryo), all pharyngeal
cartilages were underdeveloped. The ceratohyal cartilage
was even more inwardly oriented, and the Meckel’s carti-
lage was positioned more ventrally, resulting in an open-
mouth phenotype (Figures 2E–2L and Figure S5C). The
neurocranial cartilages were also underdeveloped (Figures
S5D, S5E, and S5F). Knockdown with the splice-blocking
morpholino also resulted in facial cartilage defects. These
defects were qualitatively indistinguishable from those
induced by faf1-MO-ATG (Figure S4B and Table S2).
Because morpholinos can, in certain cases, induce off-
target effects of apoptosis through nonspecific p53 activa-
tion, we wished to exclude the possibility that the faf1KD
phenotype was merely a consequence of increased CNC
apoptosis, and we therefore assessed whether the pheno-
typic changes induced by the faf1-targeting morpholinos
could be blocked by coknockdown of p53, an established
procedure in the field.30,31 At a dose of 4 ng faf1-MO-
ATG, TUNEL staining showedmore apoptosis in the neural
plate and tube and in the spinal cord in faf1KD than control
embryos from about 12 hpf (early somitogenesis) to 5 dpf
(Figure S6). Because the neural-plate border, neural plate,
and early neural tube of vertebrate embryos give rise to
CNC cells, which subsequently populate the pharyngeal
arches and give rise to all lower jaw andmany other cranial
cartilages,32,33 we coinjected a p53-targeting morpholinoThe Americathat blocks morpholino-induced apoptosis in zebrafish
embryos.30 Apoptosis in the CNS was reduced in
faf1KDp53KD morphant embryos (Figures S6C and S6F
and Table S3), but—importantly—Alcian blue staining of
3–5 dpf coinjected embryos still showed the cartilage
defects (Figures S8A and S8B and Table S3). Thus, the
faf1KD phenotype was not dependent on off-target effects
of the morpholinos used. There was also no difference in
cell proliferation in faf1KDp53KD morphant embryos
(data not shown). Nevertheless, to eliminate an off-target
increase in apoptosis as an influencing factor, we used
the double-knockdown strategy in all subsequent experi-
ments (and obtained similar findings in faf1KD embryos).Altered Expression of Chondrogenic Markers
in CNCs from faf1KD Zebrafish Embryos
We then analyzed how faf1 silencing induced the cartilage
defects. In situ hybridization using snail1b, foxd3, dlx2, and
sox10 (markers of neural-crest induction and differentia-
tion), as well as crestin (a pan-CNC marker), showed no
difference in expression between control and faf1KDp53KD
embryos (Figures S7A–S7G and data not shown) and
demonstrated that earlier CNCs were initially correctly
patterned. In contrast, sox9a (a marker of CNCs that differ-
entiate to cartilage) was detectable in mesenchymal
condensations of pharyngeal arches in control but not in
faf1KD or faf1KDp53KD 30 hpf embryos (Figures 2Q and
2R). The observed reduction in sox9a expression in
faf1KDp53KD embryos was attributable to selective
silencing of faf1 because it was rescued by coinjection of
zebrafish faf1mRNAwith the faf1-MO-Splice and p53mor-
pholino (Table S4). Of 86 faf1KDp53KD embryos, only 11
(13%) had normal sox9a expression in the first two CNC
migratory streams at 22 hpf. Upon coinjection with faf1
mRNA in a total of 126 embryos, 77 (61%) had normal
levels of sox9a expression (p < 107) (Figures S8C, S8D,
and S8E). Similarly, collagen, type II, alpha-1 (col2a1
[MIM 120140]) expression, which marks differentiated
cartilage, was reduced in the mandible of morphant
embryos at 48 hpf (Figures 2S and 2T). Furthermore, anal-
ysis of the expression pattern of EGFP in the transgenic
line Tg(fli1:eGFP)y1, which marks (late) neural crest cells,
showed that the arches were condensed and underdevel-
oped in faf1KDp53KD embryos (Figures 2O and 2P). Lack
of cartilage formation was evident at 3 dpf (Figures S8A
and S8B). This led us to investigate the role of these mole-
cules in the proband with the 46,XY,t(1;2)(p34;q33) trans-
location. Despite large variability, a tendency toward
a decrease in SOX9 expression was observed in the patient
(Figure S8F). Because COL2A1 expression is absent in
lymphoblasts, it could not be assessed in this cohort.Discussion
In this study, we demonstrate that FAF1 is disrupted in one
family affected by autosomal-dominant PRS. Although wen Journal of Human Genetics 88, 150–161, February 11, 2011 157
Figure 3. Proposed FAF1 Role in Chon-
drogenesis
NF-kB binds to IkB inhibitor in cytoplasm
in an inactive form. In the presence of
FAF1, NF-kB translocation to the nucleus
is inhibited, and SOX9 and COL2A1 are
normally expressed. In the absence of
FAF1, upon NF-kB activation by IL-1 and
TNF, subunit kinases IKK-a, -b, and -g are
activated. Phosphorylated IkB is ubiquiti-
nated and degraded. Free NF-kB translo-
cates from the cytoplasm to the nucleus
and inhibits expression of SOX9 and
COL2A1, leading to defective chondrogen-
esis (e.g., CPO). Abbreviations are as
follows: TNF, tumor necrosis factor; TNFR,
tumor necrosis factor receptor; IL-1, inter-
leukin-1; IkB, kappa light polypeptide
[arrowheads]).did not identify coding-region mutations in 368 cleft
patients, we generated compelling evidence that FAF1 is
strongly associated with CPO. We were able to replicate
those results across several populations. Overall, the TT
genotype of rs3827730 confers an approximately 1.47-
fold increase in relative risk of CPO. Although rs3827730
is not in linkage disequilibrium (LD) with the tested
SNPs, the decreased expression of FAF1 in CPO patients
suggests that changes in noncoding regions, probably in
LD with associated SNPs, play an important role, in agree-
ment with current theories on the basis of complex
diseases.9
During facial formation, as CNC cells migrate from the
hindbrain and posterior midbrain to form the pharyngeal
skeleton, they express a series of molecules specific to
delamination, migration, and fate determination.1 Sox9a
is expressed in mesenchymal condensations prior to chon-
drogenesis, and Col2a1, the major collagen of cartilage,
marks the formation of the latter.34 The friend leukemia
integration 1 gene (fli1 [MIM 193067]) is expressed in
CNC derivatives, such as the developing cartilages of the
jaw and the mesenchyme of aortic arches.35–37 In our
faf1KDp53KD zebrafish model, the expression of these three
major CNC markers was affected in the lower jaw and the
mandible. This suggests that the lack of Faf1 may disrupt158 The American Journal of Human Genetics 88, 150–161, February 11, 2011chondrogenesis by altering differenti-
ation of CNC cells derived from the
first pharyngeal arch.
Cleft palate might be caused by the
failure of the lower jaw to develop
normally. Rapid growth of the lower
jaw is needed for the tongue to
descend from between the two palatal
shelves. If not, the tongue prevents
the palate from closing, resulting in
a cleft palate.38 Because FAF1 is ex-pressed in the Meckel’s cartilage of zebrafish embryos, is
disrupted in a Pierre Robin sequence family with decreased
SOX9 expression, and associates with CPO, it might
primarily play a role in the development of the lower jaw.
FAF1 is a Fas-binding protein whose role in development
is unknown. Several lines of evidence link FAF1 to NF-kB
signaling. Overexpression of FAF1 prevents NF-kB translo-
cation to the nucleus and inhibits its activity induced by
TNF-alpha and IL-1.39 Moreover, IL-1 and TNF-alpha
downregulate Sox9 in chondrocytes, leading to downregu-
lation of Col2a1 expression, an effect mediated by the
NF-kB pathway.40 Our results thus raise the question of
whether the lack of FAF1 leads to a decrease of Sox9 and
Col2a1 as a result of insufficient inhibition of the NF-kB
inhibitory pathway (Figure 3).
NF-kB translocation to the nucleus is impaired in the
stratum spinosum in Ikka/ mice,41,42 the abnormalities
of which are similar to embryos null for Irf6, a gene
mutated in a syndrome involving cleft lip and palate.43
Moreover,mice deficient for IKK1 (IkB kinase 1) have a cleft
of the secondary palate.44 Interestingly, IKK1 inhibits the
NF-kB pathway, underscoring its role in skeletal develop-
ment.44 The disruption of SOX9 or COL2A1 leads to a cleft
palate in humans and mice.9,45–47 Moreover, autosomal-
dominant and recessive osteochondrodysplasias are
associated with mutations in COL11A1 and COL11A2,
known to encode proteins involved in COL2A1 fibril size
regulation.48,49 These facts corroborate our data for an
early role of FAF1 in facial chondrogenic development.
In conclusion, we show that FAF1 is a key player in jaw
development and that disruptions in this gene are associ-
ated with orofacial abnormalities. This expands the reper-
toire of FAF1 functions from apoptosis to development and
suggests an interconnection between these two processes.Supplemental Data
Supplemental Data include eight figures and four tables and can be
found with this article online at http://www.cell.com/AJHG/.Acknowledgments
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